VH invests €60,000 for a 30% stake in Bwell Supplements as part of its VHHub acceleration program, aiming to scale the company's operations in the booming nutritional supplement market.
Information on the Target
Bwell Supplements is an emerging player in the nutritional and sports supplement market, known for its validated product line and ambitious growth plans. The company has reached out to us seeking a strategic partner to scale its operations effectively. With a clear vision shared with VH, Bwell represents an excellent opportunity for collaboration as it looks to enhance its business model and expand its market presence.
As the first investment made under the VHHub acceleration program, Bwell embodies our commitment to fostering entrepreneurial endeavors. We envision assisting Bwell in achieving the level of success experienced by previous investments in companies like Prismalia and Euroindoor, but with a more structured management approach through our new program.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The market for nutritional and sports supplements has been growing significantly in recent years, reflecting a rising consumer awareness about health and fitness. This expansion is driven
Similar Deals
World Fund, Capnamic, Venture Stars, Caesar Ventures → Freshflow
2025
VH
invested in
Bwell Supplements
in 2025
in a Seed Stage deal
Disclosed details
Transaction Size: $64M